Since the discovery in the 1970s that plasma levels of high-density lipoprotein cholesterol
(HDL-C) are inversely associated with cardiovascular outcome, it has been postulated that …

Dyslipidemia is a commonly encountered clinical condition and is an important determinant
of cardiovascular disease. Although secondary factors play a role in clinical expression …

Lecithin: cholesterol acyltransferase (LCAT) is a key enzyme that catalyzes the esterification
of free cholesterol in plasma lipoproteins and plays a critical role in high-density lipoprotein …

HDL is known to be inversely correlated with cardiovascular disease due to its diverse
antiatherogenic functions. These functions include cholesterol efflux and reverse cholesterol …

Abstract Purpose of Review Elevated high-density lipoprotein cholesterol levels in the blood
(HDL-C) represent one of the strongest epidemiological surrogates for protection against …

The burden of atherothrombotic cardiovascular disease remains high despite currently
available optimum medical therapy. To address this substantial residual risk, the …

The association between dietary patterns and CVD risk factors among non-Hispanic whites
has not been fully studied. Data from 650 non-Hispanic white adults who participated in one …

Lecithin: cholesterol acyltransferase (LCAT), first identified by Glomset1), is a lipoprotein-
associated enzyme responsible for the synthesis of most of the plasma cholesteryl esters …

The lecithin: cholesterol acyltransferase (LCAT) enzyme is responsible for the synthesis of
cholesteryl esters in human plasma. Lecithin: cholesterol acyltransferase is a critical enzyme …

BACKGROUND: Cholesterol efflux capacity (CEC) predicts cardiovascular disease
independently of high-density lipoprotein (HDL) cholesterol levels. Isolated small HDL …